Bliss GVS Pharma Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Bliss GVS Pharma şirketinin toplam hissedar öz sermayesi ₹10.5B ve toplam borcu ₹832.9M olup, bu da borç-öz sermaye oranını 7.9% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ₹12.8B ve ₹2.3B dir. Bliss GVS Pharma 'in FAVÖK'ü ₹1.2B faiz karşılama oranı -36.2 dur. Şirketin ₹2.2B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.
Anahtar bilgiler
7.9%
Borç/özkaynak oranı
₹832.88m
Borç
| Faiz karşılama oranı | -36.2x |
| Nakit | ₹2.20b |
| Eşitlik | ₹10.48b |
| Toplam yükümlülükler | ₹2.34b |
| Toplam varlıklar | ₹12.83b |
Son finansal sağlık güncellemeleri
These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Safely
Aug 25
Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Feb 20Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Jul 14These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well
May 21Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet
Feb 08Recent updates
Investors Don't See Light At End Of Bliss GVS Pharma Limited's (NSE:BLISSGVS) Tunnel
Nov 23Here's Why Bliss GVS Pharma (NSE:BLISSGVS) Has Caught The Eye Of Investors
Oct 26These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Safely
Aug 25Bliss GVS Pharma Limited's (NSE:BLISSGVS) Prospects Need A Boost To Lift Shares
Aug 07Increases to Bliss GVS Pharma Limited's (NSE:BLISSGVS) CEO Compensation Might Cool off for now
Jul 19Bliss GVS Pharma's (NSE:BLISSGVS) Dividend Will Be ₹0.50
Jul 18Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50
Jul 04We Think Bliss GVS Pharma's (NSE:BLISSGVS) Solid Earnings Are Understated
May 10Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Right But Growth Is Lacking
Apr 27Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Feb 20There Is A Reason Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Undemanding
Jan 26Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Jul 14Bliss GVS Pharma (NSE:BLISSGVS) Has Affirmed Its Dividend Of ₹0.50
Sep 11Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50
Aug 28These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well
May 21Estimating The Intrinsic Value Of Bliss GVS Pharma Limited (NSE:BLISSGVS)
Apr 08A Look At Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Returns
Mar 18Here's How We Evaluate Bliss GVS Pharma Limited's (NSE:BLISSGVS) Dividend
Feb 25Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet
Feb 08What Type Of Shareholders Make Up Bliss GVS Pharma Limited's (NSE:BLISSGVS) Share Registry?
Jan 21Do Its Financials Have Any Role To Play In Driving Bliss GVS Pharma Limited's (NSE:BLISSGVS) Stock Up Recently?
Jan 08How Is Bliss GVS Pharma's (NSE:BLISSGVS) CEO Paid Relative To Peers?
Dec 26
Did Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Deserve to Gain 14%?
Dec 13Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?
Nov 30Bliss GVS Pharma Limited (NSE:BLISSGVS) Insiders Increased Their Holdings
Nov 18Does Bliss GVS Pharma Limited (NSE:BLISSGVS) Have A Place In Your Dividend Portfolio?
Nov 06Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: BLISSGVS 'nin kısa vadeli varlıkları ( ₹8.5B ) kısa vadeli yükümlülüklerini ( ₹1.9B ) aşıyor.
Uzun Vadeli Yükümlülükler: BLISSGVS şirketinin kısa vadeli varlıkları ( ₹8.5B ) uzun vadeli yükümlülüklerini ( ₹418.8M ) aşmaktadır.
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: BLISSGVS şirketinin toplam borcundan daha fazla nakiti var.
Borcun Azaltılması: BLISSGVS 'nin borç/öz sermaye oranı son 5 yılda 12.9% seviyesinden 7.9% seviyesine düştü.
Borç Kapsamı: BLISSGVS 'nin borcu işletme nakit akışı ( 126.1% ) tarafından iyi bir şekilde karşılanmaktadır.
Faiz Kapsamı: BLISSGVS ödediğinden daha fazla faiz kazandırıyor, dolayısıyla faiz ödemelerinin karşılanması bir sorun teşkil etmiyor.